FDA Panel Endorses Teplizumab for Delaying Type 1 Diabetes FDA Panel Endorses Teplizumab for Delaying Type 1 Diabetes

Advisory committee members cite unmet need and efficacy of this potentially ' paradigm-shifting ' therapy, but voice concerns about limited data and long-term safety.Medscape Medical News
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Diabetes & Endocrinology News Source Type: news